Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RICE Trial: Rifaximin in Chronic Hepatic Encephalopathy
NCT00364689Phase 3Terminated
- Sponsor
- University of Miami
- Start
- Aug 2006
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rifaximin in hepatic encephalopathy (HE), sponsored by University of Miami. Started Aug 2006; status: terminated.
02
Drugs
rifaximin
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT00364689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00364689.